Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market

Eterna Therapeutics (ERNA) Financial Statements

213 Followers

Eterna Therapeutics Financial Overview

Eterna Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.252; its P/E ratio is -0.42; Eterna Therapeutics is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $-2.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 47.00K$ -4.00K$ 51.00K$ 21.00K$ 21.00K
Gross Profit$ -14.00K$ -141.00K$ -69.00K$ 21.00K$ 21.00K
EBIT$ -6.17M$ -5.62M$ -5.60M$ -4.50M$ -5.41M
EBITDA$ -5.18M$ -4.88M$ -5.03M-$ -5.35M
Net Income Common Stockholders$ -6.60M$ -6.18M$ -5.59M$ -4.52M$ -5.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.12M$ 7.58M$ 4.55M$ 1.84M$ 5.40M
Total Assets$ 49.66M$ 49.13M$ 52.25M$ 46.95M$ 15.11M
Total Debt$ 47.45M$ 41.84M$ 39.60M$ 35.14M$ 1.01M
Net Debt$ 42.34M$ 34.27M$ 35.05M$ 33.30M$ -4.39M
Total Liabilities$ 53.07M$ 46.90M$ 48.69M$ 43.09M$ 7.73M
Stockholders Equity$ -3.41M$ 2.23M$ 3.56M$ 3.87M$ 7.38M
Cash Flow-
Free Cash Flow$ -3.80M$ -4.72M$ -5.80M-$ -6.03M
Operating Cash Flow$ -3.70M$ -4.70M$ -5.80M$ -3.90M$ -6.03M
Investing Cash Flow$ -97.00K$ -19.00K---
Financing Cash Flow$ 1.39M$ 7.70M$ 8.54M$ 312.00K-
Currency in USD

Eterna Therapeutics Earnings and Revenue History

Eterna Therapeutics Debt to Assets

Eterna Therapeutics Cash Flow

Eterna Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis